Zobrazeno 1 - 10
of 35
pro vyhledávání: '"B., MANEESHA"'
Publikováno v:
i-Manager's Journal on Digital Signal Processing; Jun2024, Vol. 12 Issue 1, p15-20, 6p
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 12, Iss 1, Pp 1-3 (2017)
Abstract Hereditary hemorrhagic telangiectasia (HHT) poses substantial burdens due to nosebleeds and iron deficiency resulting from recurrent hemorrhagic iron losses. Recent studies by our group found surprising links between HHT nosebleeds and certa
Externí odkaz:
https://doaj.org/article/59bfb2cb77f144f7a1b2cdaecc0de769
Publikováno v:
2022 2nd International Conference on Artificial Intelligence and Signal Processing (AISP).
Autor:
B. Maneesha
Publikováno v:
International Journal of Pure & Applied Bioscience. 7:399-404
Autor:
B. Maneesha
Publikováno v:
International Journal of Pure & Applied Bioscience. 7:364-371
Publikováno v:
Lecture Notes in Networks and Systems ISBN: 9789811582172
Nowadays, researchers are trying to reveal better consequences by acting on machine learning (ML) algorithms. The notion behind this study is to represent the fundamental machine learning algorithms and its applicability in current scenario. Backprop
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ee8bb3797c36de8104a30b5a5199e888
https://doi.org/10.1007/978-981-15-8218-9_25
https://doi.org/10.1007/978-981-15-8218-9_25
Autor:
Finnamore, Helen1,2, Silva, B. Maneesha3, Hickson, B. Mary4, Whelan, Kevin2, Shovlin, Claire L.1,5 c.shovlin@imperial.ac.uk
Publikováno v:
Orphanet Journal of Rare Diseases. 3/28/2017, Vol. 12, p1-3. 3p.
Publikováno v:
Orphanet Journal of Rare Diseases
Background Hereditary haemorrhagic telangiectasia (HHT) is inherited as an autosomal dominant trait, affects ~1 in 5,000, and causes multi-systemic vascular lesions and life-limiting complications. Life expectancy is surprisingly good, particularly f
Publikováno v:
The Laryngoscope. 123(5)
Objectives/Hypothesis To identify factors influencing the severity of epistaxis in hereditary hemorrhagic telangiectasia (HHT). Study Design Participants with and without HHT were recruited from a specialist service and online following advertisement
Publikováno v:
The Lancet. 383:S40
Background Thrombotic disease is usually treated with anticoagulant or antiplatelet agents, but the presence of a haemorrhagic disorder restricts anticoagulant use in many National Health Service Trust guidelines, including our own. Hereditary haemor